Page last updated: 2024-09-03

imatinib mesylate and Ocular Toxoplasmosis

imatinib mesylate has been researched along with Ocular Toxoplasmosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Basu, S; Biswas, G; Das, T	1

Other Studies

1 other study(ies) available for imatinib mesylate and Ocular Toxoplasmosis

Article	Year
Bilateral toxoplasma retinochoroiditis in a patient with chronic myeloid leukemia treated with imatinib mesylate. Ocular immunology and inflammation, 2010, Volume: 18, Issue:1 Topics: Antineoplastic Agents; Benzamides; Chorioretinitis; DNA; Genome; Humans; Imatinib Mesylate; Immune Tolerance; Immunoglobulin G; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Toxoplasma; Toxoplasmosis, Ocular; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Visual Acuity	2010

Article

Year

Bilateral toxoplasma retinochoroiditis in a patient with chronic myeloid leukemia treated with imatinib mesylate.

Ocular immunology and inflammation, 2010, Volume: 18, Issue:1

Topics: Antineoplastic Agents; Benzamides; Chorioretinitis; DNA; Genome; Humans; Imatinib Mesylate; Immune Tolerance; Immunoglobulin G; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Toxoplasma; Toxoplasmosis, Ocular; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Visual Acuity

2010